<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The <z:chebi fb="3" ids="16646">Zucker</z:chebi> fatty (ZF) rat subjected to 60% pancreatectomy (Px) develops moderate <z:mp ids='MP_0002055'>diabetes</z:mp> by 3 weeks </plain></SENT>
<SENT sid="1" pm="."><plain>We determined whether a progressive fall in beta cell mass and/or <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> contribute to beta cell failure in this type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> model </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Partial (60%) or sham Px was performed in ZF and <z:chebi fb="3" ids="16646">Zucker</z:chebi> lean (ZL) rats </plain></SENT>
<SENT sid="3" pm="."><plain>At 3 weeks post-surgery, beta cell mass and proliferation, proinsulin biosynthesis, pancreatic insulin content, insulin secretion, and islet <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism were measured </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: ZL-Px rats maintained <z:mpath ids='MPATH_458'>normal</z:mpath> glycaemia and <z:chebi fb="105" ids="17234">glucose</z:chebi>-stimulated insulin secretion (GSIS) despite incomplete recovery of beta cell mass possibly due to compensatory enhanced islet <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism and lipolysis </plain></SENT>
<SENT sid="5" pm="."><plain>ZF-Px rats developed moderate <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> (14 mmol/l), hypertriacylglycerolaemia and relative hypoinsulinaemia </plain></SENT>
<SENT sid="6" pm="."><plain>Despite beta cell mass recovery and <z:mpath ids='MPATH_458'>normal</z:mpath> arginine-induced insulin secretion, GSIS and pancreatic insulin content were profoundly lowered in ZF-Px rats </plain></SENT>
<SENT sid="7" pm="."><plain>Proinsulin biosynthesis was not reduced </plain></SENT>
<SENT sid="8" pm="."><plain>Compensatory increases in islet <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism above those observed in ZF-Sham rats were not seen in ZF-Px rats </plain></SENT>
<SENT sid="9" pm="."><plain>Triacylglycerol content was not increased in ZF-Px islets, possibly due to lipodetoxification by <z:mp ids='MP_0008034'>enhanced lipolysis</z:mp> and fatty acid oxidation </plain></SENT>
<SENT sid="10" pm="."><plain>Fatty acid accumulation into monoacylglycerol and diacylglycerol was increased in ZF-Px islets together with a 4.5-fold elevation in <z:chebi fb="0" ids="15541">stearoyl-CoA</z:chebi> desaturase <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS/INTERPRETATION: Falling beta cell mass, reduced proinsulin biosynthesis and islet <z:hpo ids='HP_0001397'>steatosis</z:hpo> are not implicated in early beta cell failure and glucolipotoxicity in ZF-Px rats </plain></SENT>
<SENT sid="12" pm="."><plain>Rather, severe <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> with a specific reduction in GSIS and marked <z:mpath ids='MPATH_63'>depletion</z:mpath> of beta cell insulin stores with altered <z:chebi fb="23" ids="18059">lipid</z:chebi> partitioning underlie beta cell failure in this animal model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>